Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 24 citing Young: Hyperinsulinemia and cognitive decline in a middle-aged cohort. (0.09 sec) 

Vascular risk factors, cognitve decline, and dementia


E Duron, O Hanon - Vascular Health and Risk Management, 2008 - pubmedcentral.nih.gov
Dementia is one of the most important neurological disorders in the elderly. Aging is associated
with a large increase in the prevalence and incidence of degenerative (Alzheimer's disease)
and vascular dementia, leading to a devastating loss of autonomy. In view of the ...
Cited by 21 - Related articles - BL Direct - All 8 versions

Impaired insulin secretion increases the risk of Alzheimer disease


E Ronnemaa, B Zethelius, J Sundelof, J Sundstrom, M … - Neurology, 2008 - AAN Enterprises
Results: A low insulin response at baseline was associated with a higher cumulative risk of AD
(hazard ratio for 1 SD decrease, 1.31; 95% CI, 1.10–1.56) also after adjustment for age, systolic
blood pressure, body mass index, serum cholesterol, smoking, education level, and ...
Cited by 21 - Related articles - All 4 versions

An Integrated and Unifying Hypothesis for the Metabolic Basis of Sporadic …


A Erol - Journal of Alzheimer's Disease, 2008 - IOS Press
Abstract. Acquired disturbances of several aspects of cellular metabolism appear pathologically
important in sporadic Alzheimer's disease (SAD). Among these, brain glucose utilization is reduced
in the early stages of the disease. Hyperinsulinemia, which is a characteristic finding of ...
Cited by 8 - Related articles - BL Direct - All 3 versions

Amelioration of cognitive impairment in the type-2 diabetic mouse by the …


K Tsukuda, M Mogi, JM Li, J Iwanami, LJ Min, A Sakata, … - Hypertension, 2007 - Am Heart Assoc
Angiotensin II type-1 receptor blockers are widely used with the expectation of prevention of
stroke, potential effects to ameliorate of type-2 diabetes, which seems to be closely associated
with the impairment of cognitive function in humans. Recently, we have reported that an ...
Cited by 10 - Related articles - All 4 versions

Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new …

- oxfordjournals.org
D Dickinson, PD Harvey - Schizophrenia Bulletin, 2008 - MPRC
The schizophrenia research community, including government, industry, and academia, has
made development of procognitive treatment strategies a priority. Much current research is directed
at dividing broad impairments in cognition into more delineated components that might ...
Cited by 8 - Related articles - All 3 versions

Glycemic Control and Hypoglycemia

- diabetesjournals.org
LC Perlmuter, BP Flanagan, PH Shah, SP Singh - Diabetes Care, 2008 - Am Diabetes Assoc
Diabetic patients, especially those treated with insulin, are at risk for developing
hypoglycemia. Treatment, even with oral agents such as sulfonylureas, increases this risk. Asymptomatic
episodes of hypoglycemia may constitute up to 10% of a 24-h period in diabetic patients ...
Cited by 2 - Related articles - All 4 versions

Glucose intolerance and diabetes as risk factors for cognitive impairment in people …


T Cukierman-Yaffe, HC Gerstein, C Anderson, F … - Diabetes research and …, 2009 - Elsevier
Setting and patients: The ONgoing Telmisartan Alone and in combination with Ramipril Global
Endpoint Trial (ONTARGET) and concurrent Telmisartan Randomized Assessment Study in ACE
intolerant Subjects with Cardiovascular Disease (TRANSCEND) are multi-center, ...
Cited by 2 - Related articles - All 3 versions

Metabolic links between diabetes and Alzheimers disease


PA Maher, DR Schubert - Expert Review of Neurotherapeutics, 2009 - ingentaconnect.com
There are currently over 250 million people worldwide who have been diagnosed with Type
2 diabetes (T2D) and this number is expected to double within the next 15–20 years. T2D is the
fourth leading cause of mortality and the lead- ing cause of blindness in the developed ...
Cited by 1 - Related articles - All 4 versions

Metabolic Syndrome Pathophysiology and Clinical Presentation


Y Handelsman - Toxicologic pathology, 2009 - tpx.sagepub.com
Metabolic syndrome is a relatively new definition, designed to help the health care practitioner
to easily identify people at risk for the development of cardiovascular disease and diabetes. With
the obesity epidemic, we are witnessing an epidemic of multiple-risk patients. Insulin ...
Cited by 1 - Related articles - All 4 versions

Cognitive dysfunction and its clinical and radiological determinants in patients with …


AM Tiehuis, WPTM Mali, AF van Raamt, FLJ … - Journal of the …, 2009 - Elsevier
Both vascular disease and diabetes type 2 (DM2) decrease cognitive functioning in elderly
people. It is uncertain if DM2 affects cognition independent of vascular disease. In patients with
symptomatic arterial disease, we studied the effect of DM2 on cognition and identified ...
Cited by 1 - Related articles - All 2 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google